ArticleFrontiers in immunology2026

Real-world study of efgartigimod in AChR antibody-positive generalized myasthenia gravis: thymus status, multi-domain symptom improvement and steroid-sparing effect.

Kariman Aili et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.